General Meeting - Adjournment

RNS Announcement

RNS Number : 5351H

ValiRx PLC

25 March 2020

ValiRx Plc

("ValiRx" or the "Company")

GENERAL MEETING - Adjournment

London, UK. 25 March 2020: ValiRx Plc (AIM: VAL), a clinical stage biotechnology company, provides an update on its Notice of General Meeting ("GM"), which was due to be held today at 11:00.

Due to the current COVID-19 situation, the meeting has been adjourned until further notice.

A further announcement will be made in due course.

For more information, please contact:

ValiRx plc	Tel: +44 (0) 20 7073 2628 www.valirx.com
Dr Satu Vainikka, Chief Executive	Tel: +44 (0) 20 7073 2628
Tarquin Edwards, Head of Communications.	Tel: +44 (0) 7879 458 364 [email protected]
Cairn Financial Advisers LLP - Nominated Adviser
Liam Murray / Jo Turner	Tel: +44 (0) 20 7213 0880

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

MSCEANDSALAEEEA

RNS metadata

Title: General Meeting - Adjournment
Time: 09:44:39
Date: 25 Mar 2020
Category: Miscellaneous
ID: 5351H